These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Granulocyte-macrophage colony-stimulating factor inhalation therapy for patients with idiopathic pulmonary alveolar proteinosis: a pilot study; and long-term treatment with aerosolized granulocyte-macrophage colony-stimulating factor: a case report. Tazawa R, Nakata K, Inoue Y, Nukiwa T. Respirology; 2006 Jan; 11 Suppl():S61-4. PubMed ID: 16423274 [Abstract] [Full Text] [Related]
5. [Response to inhaled granulocyte-macrophage colony-stimulating factor in a patient with alveolar proteinosis]. Rodríguez Portal JA, Rodríguez Becerra E, Sánchez Garrido A. Arch Bronconeumol; 2009 Mar; 45(3):150-2. PubMed ID: 19286115 [Abstract] [Full Text] [Related]
9. Pulmonary alveolar proteinosis. Wang T, Lazar CA, Fishbein MC, Lynch JP. Semin Respir Crit Care Med; 2012 Oct; 33(5):498-508. PubMed ID: 23001804 [Abstract] [Full Text] [Related]
10. [Pulmonary alveolar proteinosis]. Jouneau S, Kerjouan M, Briens E, Lenormand JP, Meunier C, Letheulle J, Chiforeanu D, Lainé-Caroff C, Desrues B, Delaval P. Rev Mal Respir; 2014 Dec; 31(10):975-91. PubMed ID: 25496792 [Abstract] [Full Text] [Related]
11. [Congenital pulmonary alveolar proteinosis: a case report]. Pissarra S, Rocha G, Acevedo I, Guimarães H. Acta Med Port; 2005 Dec; 18(2):163-8. PubMed ID: 16202349 [Abstract] [Full Text] [Related]
12. Combined-modality therapy for pulmonary alveolar proteinosis in a remote setting: a case report. Boyce DSK, Lee JW, Shah P, Freeman JH, Aboudara MC, Hostler DC. BMC Pulm Med; 2019 Mar 12; 19(1):61. PubMed ID: 30866900 [Abstract] [Full Text] [Related]
13. [Pulmonary alveolar proteinosis and its treatment with total pulmonary lavage in the Czech Republic]. Jansa P, Stríteský M, Homolka J. Vnitr Lek; 2002 Jan 12; 48(1):34-7. PubMed ID: 11852585 [Abstract] [Full Text] [Related]
14. [Autoantibody against granulocyte-macrophage colony-stimulating factor and other serum markers in pulmonary alveolar proteinosis]. Xu KF, Chen Y, Guo ZJ, Zhu YJ. Zhonghua Jie He He Hu Xi Za Zhi; 2004 Dec 12; 27(12):824-8. PubMed ID: 15730782 [Abstract] [Full Text] [Related]
15. A combination therapy of whole lung lavage and GM-CSF inhalation in pulmonary alveolar proteinosis. Yamamoto H, Yamaguchi E, Agata H, Kandatsu N, Komatsu T, Kawai S, Baba K, Awaya T, Nishikomori R, Tsurusawa M, Nakata K. Pediatr Pulmonol; 2008 Aug 12; 43(8):828-30. PubMed ID: 18618617 [Abstract] [Full Text] [Related]
16. Therapy options in pulmonary alveolar proteinosis. Luisetti M, Kadija Z, Mariani F, Rodi G, Campo I, Trapnell BC. Ther Adv Respir Dis; 2010 Aug 12; 4(4):239-48. PubMed ID: 20647242 [Abstract] [Full Text] [Related]
17. Pulmonary alveolar proteinosis with myeloproliferative syndrome with myelodysplasia: bronchoalveolar lavage reduces white blood cell count. Pollack SM, Gutierrez G, Ascensao J. Am J Hematol; 2006 Aug 12; 81(8):634-8. PubMed ID: 16906593 [Abstract] [Full Text] [Related]
19. Pulmonary alveolar proteinosis in children. de Blic J. Paediatr Respir Rev; 2004 Dec 12; 5(4):316-22. PubMed ID: 15531257 [Abstract] [Full Text] [Related]
20. [Pulmonary alveolar proteinosis: a disease caused by surfactant accumulation, and new treatment with sargramostim]. Huisman P, Grutters JC, van den Bosch JM. Ned Tijdschr Geneeskd; 2008 Jun 28; 152(26):1450-4. PubMed ID: 18666660 [Abstract] [Full Text] [Related] Page: [Next] [New Search]